Clinical Trial Update: Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating one cycle of adjuvant BEP chemotherapy in high-risk stage I non-seminomatous germ cell tumor of the testis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Testicular Cancer
• Testicular Germ Cell Tumor

Drugs mentioned

• Blenoxane (bleomycin)
• Platinol (cisplatin)
• VePesid (etoposide)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Stage I Testicular Non-Seminomatous Germ Cell Tumor | Phase 3 | Status: COMPLETED